FAIRFIELD, Conn., July 14, 2010 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (NYSE Amex:CTT) today announced that the Securities and Exchange Commission (SEC) has declared its S-1 Registration statement effective. This will allow CTT to proceed with its sale of 2 million shares of CTT common stock to Crisnic Fund. The fund raise will provide CTT capital to more aggressively sell its non-invasive Calmare Pain Therapy Treatment device and to increase shareholder equity toward meeting the NYSE Amex listing requirement.
